A cosmetic formula prototype should be approved against a written brief, not merely because its texture or fragrance seems appealing. Before approving a sample, a brand needs to check whether it meets the intended product profile, identify measurable and sensory issues, record changes, and determine which safety, stability, packaging, and regulatory evaluations remain outstanding. A successful initial review is a decision to progress development—not proof that a finished cosmetic is ready for sale.
For teams managing cosmetic formula development with an external R&D partner, a consistent review method reduces ambiguous feedback. It also helps formulation scientists distinguish a preference change from a technical failure. The following approach covers acceptance criteria, revision decisions, documentation, and the limits of an early-stage prototype.
Agree on the evaluation brief before the samples arrive. Otherwise, the development team may judge a prototype against goals that were never communicated. Start with product category, intended use, user experience, packaging concept, target markets, ingredient restrictions, and commercial constraints. Separate non-negotiable requirements from preferences.
| Brief element | Useful definition | How to check it |
|---|---|---|
| Product and use | Rinse-off facial cleanser, leave-on cream, or another defined product | Compare prototype use and format with the agreed concept |
| Sensory target | Desired spread, foam, residue, scent, and appearance, as relevant | Use a common evaluation procedure and reference sample where available |
| Packaging concept | Pump, tube, jar, or other proposed delivery system | Perform preliminary dispensing checks and plan compatibility work |
| Ingredient and market constraints | Restricted materials, positioning, and intended sales jurisdictions | Flag items for formulation and regulatory review |
| Cost and production assumptions | Indicative cost target and intended manufacturing conditions | Review feasibility separately from the sensory score |
A brand exploring different cleanser formats can first review LANDIVINE’s formula development range to understand the types of formulation concepts publicly shown. The category itself does not establish a fixed prototype delivery schedule or acceptance service.
Record what an evaluator actually observes: color uniformity, visible particles, odor, spreading behavior, stickiness, rinsability, or foam characteristics. The relevant attributes depend on the product. A facial cleanser requires an assessment of rinsing and cleansing experience; a leave-on cream may require greater attention to spread, after-feel, and application uniformity. Avoid recording only “good” or “bad.” Define the condition, sample version, and specific observation so the formulator can reproduce the evaluation.
Visible separation, sediment, unexpected thickening, changes in color, or changes in odor may require investigation. Where relevant, the R&D team can track pH, viscosity, and other formulation-specific properties under specified conditions. There is no universal target pH or viscosity for every cosmetic product. An apparently stable sample after a short observation period is not evidence of a validated shelf life, preservative effectiveness, or finished-product safety.
Test whether the prototype can be dispensed and used in the proposed package. A viscous product may not function well in a particular pump, even if it looks acceptable in a laboratory jar. Packaging contact may also require longer-term evaluation of formula changes, discoloration, leakage, or material interactions. Preliminary dispensing is therefore a useful screening step, not a replacement for a packaging compatibility study.
Translate preferences into observable evidence wherever practical. Create two classes: mandatory criteria that must be met before progression, and preferred criteria that can be optimized in subsequent work. Give each finding a status—pass, revise, or test further—rather than assigning an unexplained overall score.
| Review criterion | Evidence to retain | Possible decision |
|---|---|---|
| Product identity and use | Match to brief, sample ID, and intended use | Pass or revise |
| Appearance and scent | Defined observations under consistent conditions | Pass or revise |
| Sensory experience | Evaluation notes tied to a defined test method | Pass, revise, or compare again |
| Physical properties | Relevant measured results and test conditions | Pass, revise, or investigate |
| Packaging suitability | Dispensing observations and planned compatibility tests | Proceed with further testing or revise |
Acceptance should be stage-specific. A brand may accept a prototype’s sensory profile while withholding approval for commercial launch until the remaining evaluations are completed. Documenting this distinction prevents an informal sample approval from being mistaken for regulatory or production clearance.
Make a revision request when a defined attribute misses the brief—for example, a rinse-off cleanser leaves more residue than the agreed sensory benchmark. Specify where the mismatch appears, how often it occurs, and whether it affects a mandatory requirement. Do not direct the laboratory to add a specific ingredient without considering the whole formula: surfactants, rheology modifiers, fragrance, and other components can interact.
A visible defect is a reason to investigate, not a diagnosis. Separation could have several potential causes; the team should review the composition, processing conditions, storage history, and relevant measurements before selecting a corrective change. Every new version should carry its own identifier and test record because a correction can alter other properties.
If repeated iterations trade one mandatory attribute for another, revisit the target rather than cycling through cosmetic changes indefinitely. Packaging, cost, restricted ingredients, and the desired texture may create conflicting constraints. The project team should explicitly agree which requirement can change and which cannot.
A useful prototype review packet identifies the sample and the decision history. Depending on the project, ask for:
These are recommended project controls, not a promise that every supplier provides an identical document set. Missing information should be tracked as an action item rather than filled in by assumption.
LANDIVINE lists Radiance Comfort Cleanser in its Formula Development / Cleansing category. Its public product record identifies it as a rinse-off facial cleansing concept, with a cream/lotion dosage form and a recorded formula version. This illustrates how use method, category, product identity, and version can become concrete review fields, rather than leaving the prototype described simply as “a cleanser.”
The product page also states that a 14-day initial stability test was completed. That is a limited, product-specific public statement; it does not establish the test protocol, results against all relevant specifications, long-term shelf life, packaging compatibility, or commercial readiness. A buyer assessing that formulation would still need the appropriate technical records and a validation plan for the intended finished product. No particular LANDIVINE customer project or independent test outcome is implied here.
A prototype is ready to progress when the agreed stage-gate criteria have been met, significant deviations are resolved or formally accepted for investigation, and unfinished work has an owner and schedule. This can justify a move to the next controlled stage of formulation development. It should not be described as approval for manufacture, regulatory compliance, or sale.
For a practical handover, retain a signed review record: sample ID, decision, accepted attributes, outstanding tests, revision requests, and the next decision date. When a new formula is issued, reassess any attribute potentially affected by the change.
There is no universally reliable number. Complexity, clarity of the brief, target sensory profile, raw-material constraints, and test findings determine whether one or several revisions are needed. Agree on review rules and change handling rather than assuming a fixed number of rounds.
No. A visually acceptable sample still needs the relevant stability, microbiological, packaging, safety, and regulatory assessments for its product type and markets. Short-term appearance is only one observation.
The responsible brand or project owner should define the approval authority, with input from formulation, quality, regulatory, and packaging teams as appropriate. A sensory sign-off should be distinguished from final product release authorization.
Send the sample version, assessment date, test conditions, observed issues, whether each issue blocks progression, and the specific change requested. This is more actionable than a general request to make the product “feel more premium.”
Before approving the next stage, verify that the prototype matches a documented brief, that subjective observations and objective tests are recorded separately, that revisions are traceable, and that unfinished validation is clearly identified. For a project-specific discussion, a brand can share its formulation brief and prototype review requirements with LANDIVINE. Include the product type, intended market, packaging plan, and the specific evaluation questions that need resolution.
Previous News
Cosmetic Gel Formulation Development: Polymer S...Next News
Marine Algae in Cosmetics: An Ingredient Identi...